Ziqitza Healthcare launches 112 ERV in Odisha, 104 Helpline in Chhattisgarh

IMT News Desk
IMT News Desk
· 2 min read

112 emergency response vehicles will act in similar lines to that of a PCR van

Ziqitza Healthcare has successfully deployed 61 ERV out of 106 numbers of 112 emergency response vehicles in the first phase in Odisha and 104 Health Helpline Services in Chhattisgarh. Ziqitza won these contracts through a competitive bid process. 

These new 112 emergency response vehicles will act in similar lines to that of a PCR van. But to manage the tasks more efficiently these new vans have been equipped with modern systems such as GIS and GPS. This new service aims to address the distress calls by the citizens in a more coordinated manner.  

Sabyasachi Biswal, State Head, Ziqitza Healthcare, “Earlier Odisha government has launched an all-encompassing-encompassing emergency helpline number ‘112’ to bring police, fire brigade, ambulance and other services under the Emergency Response Support System (ERSS). The launch of these new 61 ERVs out of 106 ERVs, is in line with state government’s effort in strengthening the 112 services. This initiative will be a key enabler to ensure timely response in case of any emergency and a boom to the 4.3 crore population of the state.” 

The 104-helpline number offers all-around medical assistance to people in four major areas. These are medical advice, medical information, counselling and complaint registration. Under the medical information section, queries by people about hospitals, other institutions, diagnostic services etc. are resolved. 

Chandan Datta, Business Head, Ziqitza Healthcare said, “With the help of 112 ERV in Odisha & 104 helplines in Chhattisgarh, we are committed to helping people in distress. We deeply appreciate the support and cooperation we have received from the state government agencies and NHM – Both Odisha & Chhattisgarh that have allowed us to serve the people of the states. The 112 initiatives will be a key enabler to ensure timely response in case of any emergency. Also, 104 helpline aims to provide people one-stop solution for any advice or information relating to their health and we would like to urge people to avail this service to get solutions for their health-related queries.”

 

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk